Koers Omni Bio Pharmaceutical Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 10,89 mln. 10,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -7 mln. -6,5 mln. | Nettowinst (verlies) 2014 | -2 mln. -1,86 mln. | EV/omzet 2013 | - |
Nettoschuld 2013 | 441K 410K | Nettoschuld 2014 | 752K 699K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-1,5
x | K/w-verhouding 2014 |
-4,18
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,43% | 103 mld. | |
+8,96% | 101 mld. | |
+4,40% | 23,07 mld. | |
-12,15% | 22,23 mld. | |
-4,36% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,04% | 16,94 mld. | |
+6,79% | 14,07 mld. | |
+38,61% | 12,35 mld. |